Free Trial
NASDAQ:PLSE

Pulse Biosciences (PLSE) Stock Price, News & Analysis

Pulse Biosciences logo
$16.89 +0.03 (+0.18%)
Closing price 04:00 PM Eastern
Extended Trading
$16.87 -0.02 (-0.12%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Pulse Biosciences Stock (NASDAQ:PLSE)

Key Stats

Today's Range
$16.56
$17.16
50-Day Range
$14.48
$19.27
52-Week Range
$9.70
$25.00
Volume
152,222 shs
Average Volume
194,299 shs
Market Capitalization
$1.14 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Pulse Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

PLSE MarketRank™: 

Pulse Biosciences scored higher than 16% of companies evaluated by MarketBeat, and ranked 855th out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Pulse Biosciences.

  • Percentage of Shares Shorted

    18.95% of the float of Pulse Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulse Biosciences has a short interest ratio ("days to cover") of 12.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pulse Biosciences has recently increased by 1.28%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Pulse Biosciences does not currently pay a dividend.

  • Dividend Growth

    Pulse Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    18.95% of the float of Pulse Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulse Biosciences has a short interest ratio ("days to cover") of 12.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pulse Biosciences has recently increased by 1.28%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Pulse Biosciences has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Pulse Biosciences this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Pulse Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    71.50% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.95% of the stock of Pulse Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Pulse Biosciences' insider trading history.
Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PLSE Stock News Headlines

Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
See More Headlines

PLSE Stock Analysis - Frequently Asked Questions

Pulse Biosciences' stock was trading at $17.41 at the beginning of the year. Since then, PLSE shares have decreased by 3.0% and is now trading at $16.89.
View the best growth stocks for 2025 here
.

Pulse Biosciences, Inc. (NASDAQ:PLSE) issued its quarterly earnings results on Thursday, May, 8th. The company reported ($0.25) earnings per share for the quarter.
Read the conference call transcript
.

Pulse Biosciences (PLSE) raised $20 million in an initial public offering (IPO) on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

Top institutional investors of Pulse Biosciences include Griffin Asset Management Inc. (0.35%), Westside Investment Management Inc. (0.09%), Nuveen LLC (0.08%) and Panoramic Capital LLC (0.08%). Insiders that own company stock include Robert W Duggan, Mitchell E Levinson, Mitchell E Levinson, Burke Thomas Barrett and Kevin Patrick Danahy.
View institutional ownership trends
.

Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Novo Nordisk A/S (NVO) and Jabil (JBL).

Company Calendar

Last Earnings
5/08/2025
Today
5/23/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PLSE
Fax
N/A
Employees
140
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-42,210,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$700,000.00
Price / Cash Flow
N/A
Book Value
$0.81 per share
Price / Book
20.90

Miscellaneous

Free Float
17,532,000
Market Cap
$1.14 billion
Optionable
Optionable
Beta
1.60
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PLSE) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners